Inflammatory conditions, like in autoimmune diseases may result in conversion of FOXP3 + Tregs into Th17 cells, contributing to disease progression and impairing immune homeostasis, therefore stable full length expression of FOXP3 is a prerequisite for Treg cell therapy [21]. Here, FOXP3 is linked to autoimmune disease.